Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience

医学 鼻咽癌 放射治疗 化疗 诱导化疗 咽痛 阶段(地层学) 回顾性队列研究 内科学 放化疗 外科 肿瘤科 古生物学 生物 食管
作者
A. Jouin,Sylvie Helfré,Stéphanie Bolle,L. Claude,A. Laprie,Émilie Bogart,C. Vigneron,H. Potet,A. Ducassou,Audrey Claren,F.-G. Riet,Marie Pierre Castex,Cécile Faure‐Conter,Brice Fresneau,Anne‐Sophie Defachelles,Daniel Orbach
出处
期刊:Strahlentherapie Und Onkologie [Springer Science+Business Media]
卷期号:195 (6): 504-516 被引量:21
标识
DOI:10.1007/s00066-019-01461-6
摘要

The aim of this study was to retrospectively study survival and long-term morbidities of children with nasopharyngeal carcinoma (NPC) treated by induction chemotherapy and concurrent chemoradiation (CRT). The total dose of radiation was adapted to the response following neoadjuvant chemotherapy. Children with non-metastatic NPC treated in France between 1999 and 2015 were retrospectively included in the study. The strategy combined neoadjuvant platinum-based chemotherapy, followed by adapted CRT to tumor response. In total, 95 patients (median age 15 years [range, 7–23 years], male-to-female ratio 1.8) with undifferentiated NPC were included; 59% of patients had TNM stage IV. Intensity-modulated radiotherapy (IMRT) was delivered to 57 patients (60%), while the other patients were treated with conformal RT (3D-RT). After a median follow-up of 4.5 years [range, 3.6–5.5 years], 13 relapses and seven deaths had occurred. The 3‑year overall and relapse-free survival (RFS) were 94% [95% CI, 85–97%] and 86% [77–92%], respectively. The locoregional failure rate was 6% [95% CI, 2–14]. Long-term treatment-related sequelae of grade 2+ were reported by 37 (50%) patients; odynophagia was significantly reduced treated by IMRT vs. conventional 3D-RT (7% vs. 55%, p = 0.015). Using a reduction dose of 59.4 Gy, 54 Gy, and 45 Gy, respectively, to the primary, involved, and uninvolved neck nodes, after a favorable tumor response, was not associated with an increased locoregional failure rate. The survival rates for NPC have been considerably improved by means of multimodal therapy, but long-term locoregional morbidity remains common. Use of IMRT may induce less residual odynophagia. Radiation dose reduction adapted to chemotherapy response does not have a negative impact on outcome. These findings support the use of an RT protocol adapted to the tumor response to neoadjuvant chemotherapy for a long-lasting improvement in the patient’s quality of life.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yu完成签到 ,获得积分10
2秒前
2秒前
superpharm发布了新的文献求助10
2秒前
lcjynwe完成签到,获得积分10
3秒前
Sam十九完成签到,获得积分10
3秒前
4秒前
531完成签到,获得积分10
5秒前
5秒前
xzz完成签到 ,获得积分10
5秒前
moxi摩西完成签到,获得积分10
6秒前
langwang发布了新的文献求助10
7秒前
7秒前
腿毛怪大叔完成签到,获得积分10
7秒前
star发布了新的文献求助10
7秒前
季云完成签到,获得积分10
8秒前
Ann完成签到,获得积分0
8秒前
林泽玉完成签到,获得积分10
8秒前
郝煜祺完成签到,获得积分10
8秒前
chinaproteome发布了新的文献求助10
9秒前
sduwl完成签到,获得积分10
10秒前
superpharm完成签到,获得积分10
11秒前
所所应助fighting采纳,获得10
13秒前
鱼会淹死吗完成签到,获得积分0
13秒前
高高的哈密瓜完成签到 ,获得积分10
14秒前
Ava应助qqa采纳,获得10
14秒前
村口烫头祁师傅完成签到,获得积分10
14秒前
科研通AI6.2应助隐居采纳,获得10
14秒前
语嘘嘘完成签到,获得积分10
15秒前
Tammy完成签到,获得积分10
15秒前
陶醉人达完成签到 ,获得积分10
17秒前
MARVERICK完成签到,获得积分10
17秒前
19秒前
思源应助chinaproteome采纳,获得10
19秒前
谦让谷兰完成签到,获得积分10
19秒前
HYH发布了新的文献求助10
19秒前
蓝莓小蛋糕完成签到 ,获得积分10
22秒前
栀蓝完成签到 ,获得积分10
24秒前
唐盼烟发布了新的文献求助10
24秒前
悦耳的海燕完成签到 ,获得积分10
25秒前
好哥哥完成签到,获得积分0
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Various Faces of Animal Metaphor in English and Polish 800
Signals, Systems, and Signal Processing 610
Photodetectors: From Ultraviolet to Infrared 500
On the Dragon Seas, a sailor's adventures in the far east 500
Yangtze Reminiscences. Some Notes And Recollections Of Service With The China Navigation Company Ltd., 1925-1939 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6348511
求助须知:如何正确求助?哪些是违规求助? 8163513
关于积分的说明 17174198
捐赠科研通 5404952
什么是DOI,文献DOI怎么找? 2861862
邀请新用户注册赠送积分活动 1839623
关于科研通互助平台的介绍 1688936